TRAF7, SMO, AKT1, and KLF4 mutations, referred to as “non-NF2,” are typically found in lower-grade meningiomas, characterized by fewer chromosomal abnormalities, and generally result in better clinical outcomes [24]. The gene discussed is NF2; the disease is meningioma.